Novel Influenza Vaccines: From Research and Development (R&D) Challenges to Regulatory Responses

Influenza vaccines faced significant challenges in achieving sufficient protective efficacy and production efficiency in the past. In recent decades, novel influenza vaccines, characterized by efficient and scalable production, advanced platforms, and new adjuvant technologies, have overcome some of...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Xiangchuan, Zhang, Tianxiang, Huan, Shitong, Yang, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610648/
https://www.ncbi.nlm.nih.gov/pubmed/37896976
http://dx.doi.org/10.3390/vaccines11101573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610648/
https://www.ncbi.nlm.nih.gov/pubmed/37896976
http://dx.doi.org/10.3390/vaccines11101573

Ejemplares similares